Technopath Clinical Diagnostics
Technopath Clinical Diagnostics, an Ireland-based LGC Group subsidiary, develops and manufactures Multichem third-party quality control materials and IAMQC informatics software for clinical laboratories worldwide, distributed globally through Abbott Diagnostics.
- Company typePrivate
- Founded2004
- HeadquartersTipperary, Ireland
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Technopath Clinical Diagnostics does
Technopath Clinical Diagnostics is an Ireland-based developer and manufacturer of third-party quality control (QC) materials and informatics software for clinical laboratories, operating as a subsidiary of LGC Clinical Diagnostics within the London-listed LGC Group. The company's core technology comprises Multichem® QC materials in a proprietary frozen liquid stable, ready-to-use vial format spanning clinical chemistry, immunoassay, cardiac markers (including High Sensitive Troponin), infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant drugs, coagulation, mass spectrometry, and COVID-19 testing applications. Its IAMQC® software platform — including IAMQC Peer for cross-laboratory peer comparison reporting and IAMQC Infinity for next-generation QC data management — provides subscription-based automated quality control monitoring and reporting.
The company serves hospital laboratories, reference laboratories, and commercial clinical testing facilities globally, with reference customers including Northwell Health (USA), PathCare (South Africa), and Ramon y Cajal Hospital (Spain). Technopath generates revenue through three streams: consumable QC material sales (recurring volume), IAMQC software subscriptions, and IVD raw materials supply to IVD manufacturers. Its go-to-market combines enterprise field sales targeting major laboratories and healthcare systems with a global distribution partnership with Abbott Diagnostics Division established in 2012, under which Technopath holds exclusive status as the only Abbott-approved onboard third-party QC provider for Alinity ci systems. Products meet CLIA, CLSI, CAP, RiliBÄK, and ISO accreditation requirements, addressing regulatory compliance, cost efficiency, and automated monitoring pain points for clinical laboratories.
Technopath Clinical Diagnostics firmographics
Firmographics- Name
- Technopath Clinical Diagnostics
- Legal name
- Technopath Clinical Diagnostics
- Website
- https://technopathclinicaldiagnostics.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Short description
- Technopath Clinical Diagnostics, an Ireland-based LGC Group subsidiary, develops and manufactures Multichem third-party quality control materials and IAMQC informatics software for clinical laboratories worldwide, distributed globally through Abbott Diagnostics.
- Ownership category
- akta.pro rank
Technopath Clinical Diagnostics industry classification
Industry- Product category
- Clinical Diagnostics Quality Control Materials
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)
- akta.pro secondary industries
- Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity) (HLAHAAAO), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)
Keywords
Where Technopath Clinical Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Tipperary
- HQ country
- Ireland
- HQ region
- Europe
Offices1 record
Markets served
Technopath Clinical Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Quality Control Materials: Sale of Multichem third-party quality control materials for clinical chemistry, immunoassay, cardiac, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, mass spectrometry, and COVID-19 testing applications. Products are sold in frozen liquid stable formats as ready-to-use vials.
- IAMQC Software Solutions: Subscription-based access to IAMQC Peer and IAMQC Infinity informatics platforms providing automated QC monitoring, peer comparison reporting, and XML configuration capabilities for laboratory quality management.
- IVD Raw Materials: Supply of in vitro diagnostic raw materials to IVD manufacturers.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Technopath Clinical Diagnostics product offering
Product offeringCore offering
Technopath develops and manufactures Multichem third-party quality control materials in frozen liquid-stable, ready-to-use formats spanning cardiac, COVID-19, immunoassay, clinical chemistry, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, mass spectrometry, and barcoded QC applications for clinical laboratories. The company complements these materials with IAMQC informatics software (IAMQC Peer and IAMQC Infinity) for automated QC monitoring, peer comparison reporting, and onboard integration with Abbott Alinity ci analyzers, and supplies IVD raw materials to instrument manufacturers.
Product overview
Technopath Clinical Diagnostics is a leading global developer and manufacturer of quality control (QC) materials and software solutions for clinical laboratories. The product portfolio comprises two core offerings: (1) Multichem® Third Party Quality Control Materials — a comprehensive suite of frozen liquid stable, ready-to-use QC materials spanning cardiac markers (including Multichem hsTn), COVID-19, immunoassay, clinical chemistry, infectious diseases, immunology, urine chemistry, diabetes, fertility (Multichem AMH), immunosuppressant drugs, coagulation (Multichem D-Dimer), barcoded solutions, and mass spectrometry; and (2) IAMQC® Informatics Solutions — software products including IAMQC Peer for peer comparison reporting and IAMQC Infinity for next-generation QC data management. Technopath also offers IVD Raw Materials and holds Abbott approval as an onboard third-party QC provider for Abbott Alinity ci systems.
Differentiator
Problem solved
Functional benefit
Brands
- Multichem: Third party quality control materials brand covering cardiac, COVID-19, immunoassay, clinical chemistry, infectious diseases, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, barcoded QC solutions, and mass spectrometry.
- IAMQC
Products and services
- Multichem Third Party Quality Control Materials Comprehensive suite of third-party quality control materials in frozen liquid-stable, ready-to-use formats for clinical laboratories performing routine and specialty diagnostic testing across multiple instrument platforms.
- Multichem hsTn (High Sensitive Troponin) Third-party high-sensitive troponin QC in frozen liquid-stable format for cardiac biomarker testing in clinical laboratories.
- Multichem COVID-19 Quality control material for COVID-19 diagnostic testing in clinical laboratories.
- Multichem Immunoassay Quality control material for immunoassay testing on clinical chemistry analyzers.
- Multichem Clinical Chemistry Quality control material for clinical chemistry analyzer testing in clinical laboratories.
- Multichem Cardiac Quality control material for cardiac testing including troponin and other cardiac biomarkers.
- Multichem Infectious Disease Quality control material for infectious disease testing in clinical laboratories.
- Multichem Immunology Quality control material for immunology testing in clinical laboratories.
- Multichem Urine Chemistry Quality control material for urine chemistry analysis in clinical laboratories.
- Multichem Diabetes Quality control material for diabetes testing in clinical laboratories.
- Multichem AMH (Fertility) Quality control material for Anti-Mullerian Hormone (AMH) fertility testing in clinical laboratories.
- Multichem Immunosuppressant Quality control material for immunosuppressant drug monitoring in clinical laboratories.
- Multichem D-Dimer (Coagulation) Quality control material for D-Dimer coagulation testing in clinical laboratories.
- Multichem Barcoded QC Solutions Barcoded quality control solutions for automated tracking and management in laboratory settings.
- Multichem Mass Spectrometry Quality control material for mass spectrometry applications in clinical laboratories.
- Multichem Abbott Alinity QC Automated quality control product for Abbott Alinity ci systems, enabling onboard third-party QC directly on the analyzer. Technopath is the only Abbott-approved onboard third-party QC provider for Alinity ci systems.
- IAMQC Peer Peer-comparison software that enables laboratories to compare QC results with other laboratories using the same instruments and methods.
- IAMQC Infinity Next-generation QC informatics solution for automated quality control monitoring, reporting, and laboratory quality management.
- IVD Raw Materials Raw materials supplied to in vitro diagnostic (IVD) manufacturers for use in diagnostic test production.
Quantifiable outcome
- Important savings in terms of time and costs compared to non-consolidated QC materials
- +2 more outcomes
Companies that use Technopath Clinical Diagnostics
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Technopath Clinical Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Technopath Clinical Diagnostics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- Abbott Diagnostics DivisioncoreGlobal product development, supply and distribution agreement signed in 2012. Abbott distributes Technopath's third-party quality controls worldwide. Technopath is the only Abbott-approved onboard third party QC provider for Alinity ci systems. The partnership enables Abbott to offer market-leading third-party QC options to its global customer base.
- LGC Clinical DiagnosticsflagshipTechnopath is part of LGC Clinical Diagnostics. LGC acquired Technopath Clinical Diagnostics to strengthen its position in clinical quality controls. LGC is listed on the London Stock Exchange.
- Northwell HealthcoreEstablished collaboration in 2017. Northwell Health, New York's largest healthcare provider with over 30 million tests annually, converted to Technopath QC solutions. Northwell provides customer testimonials and case study reference for Technopath.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Technopath Clinical Diagnostics competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Technopath Clinical Diagnostics social profiles
Digital presenceTechnopath Clinical Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Technopath Clinical Diagnostics leadership team
Management profileNumber of profiles
Technopath Clinical Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Technopath Clinical Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Technopath Clinical Diagnostics
What does Technopath Clinical Diagnostics do?
Technopath develops and manufactures Multichem third-party quality control materials in frozen liquid-stable, ready-to-use formats spanning cardiac, COVID-19, immunoassay, clinical chemistry, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, mass spectrometry, and barcoded QC applications for clinical laboratories. The company complements these materials with IAMQC informatics software (IAMQC Peer and IAMQC Infinity) for automated QC monitoring, peer comparison reporting, and onboard integration with Abbott Alinity ci analyzers, and supplies IVD raw materials to instrument manufacturers.
Is Technopath Clinical Diagnostics a public or private company?
Technopath Clinical Diagnostics is a private company. It is classified as corporate owned and is currently operating.
When was Technopath Clinical Diagnostics founded?
Technopath Clinical Diagnostics was founded in 2004.
Where is Technopath Clinical Diagnostics based?
Technopath Clinical Diagnostics is headquartered in Tipperary, Ireland, in the Europe region.
How does Technopath Clinical Diagnostics make money?
Three revenue lines are on record. Quality Control Materials are the primary driver. The others are IAMQC Software Solutions and IVD Raw Materials.
Does Technopath Clinical Diagnostics have an API?
No public API is recorded for Technopath Clinical Diagnostics.
What industry is Technopath Clinical Diagnostics in?
Technopath Clinical Diagnostics's product category is Clinical Diagnostics Quality Control Materials. Its primary akta.pro industry code is HLAHAAAL, Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables), with a secondary code of HLAHAAAO, Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity). Its NAICS code is 325413 and its SIC code is 2835.